Warning Letter Wednesday® Posts
A weekly exploration of FDA warning letters and enforcement trends
Takeaway -
Small issues signify deeper noncompliance
Takeaway -
Small words can drastically increase claim risk
Takeaway -
Ensure 483 responses are complete
Takeaway -
Safety related product claims attract scrutiny
Takeaway -
Amazon compliance still needs improving
Takeaway -
Trustpilot reviews can be “marketing”
Takeaway -
Be nice to FDA investigators & follow inspection SOPs
Takeaway -
Marketing strategies should consider “reasonable consumer expectations” to avoid issues
Takeaway -
Functional mushroom products under increased scrutiny
Takeaway -
NAD challenge cases explored
Takeaway -
Nutrition fact panels must be in a compliant format
Takeaway -
Free products should also be disclosed